Doctors are challenged to engage in research for their career progression (publish or perish policy), but clinically relevant large studies with long follow-up periods are difficult to achieve.
The team has used these cells and new gene-editing techniques to test the role of genetic variants associated with diabetes, and then screen for drugs that block disease progression, as published recently in Cell Stem Cell and Nature Communications.
A very early report about the association between altered cell adhesion and tumour progression was published by a pathologist almost 60 years ago (Coman, 1944).
The criteria and cut-off values used to define the outcome categories (appropriate, late and inappropriate referral) were defined from expert opinions based on diagnostic criteria, known risk factors of curve progression and published indications for treatment [ 20, 21, 28– 39].
1 Given that our TT arm has the lowest fibrosis progression rate published so far lower than sirolimus— 26 and that there is some evidence that azathioprine is better than mycophenalate, 5 our TT regimen could be considered as a first choice for patients transplanted for HCV cirrhosis, until other evidence proves otherwise.
We used the progression rates from Thein et al. [ 29], a recent meta-analysis of published progression rates from 111 studies of individuals with chronic HCV infection.
The administration of BVZ plus first-line chemotherapy (paclitaxel, docetaxel) in the treatment of advanced breast carcinoma has lead to better outcomes in terms of response rate and time to progression in previous published studies.
Recently the first two large trials with drugs that may slow disease progression have been published: a phase 2, passive immunization trial with bapineuzumab; and a phase 3 trial with tarenflurbil, a modulator of γ-secretase.
However, our sample had a lower mortality rate and similar incidence of sepsis progression compared to previously published studies with comparable objectives [1, 24].
Harrison wrote the chord progression of his first published song, "Don't Bother Me" (1963), almost exclusively in the Dorian mode, demonstrating an interest in exotic tones that eventually culminated in his embrace of Indian music.
